NEW SELECTIVE COMT INHIBITORS - USEFUL ADJUNCTS FOR PARKINSONS-DISEASE

被引：116

作者：

MANNISTO, PT ^{[1
]}

KAAKKOLA, S ^{[1
]}

机构：

[1] UNIV HELSINKI,DEPT NEUROL,SF-00290 HELSINKI 29,FINLAND

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1989年 / 10卷 / 02期

关键词：

D O I：

10.1016/0165-6147(89)90075-8

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：54 / 56

页数：3

共 27 条

[1] DECARBOXYLASE INHIBITORS [J].

BARTHOLINI, G ;

PLETSCHER, A .

PHARMACOLOGY & THERAPEUTICS PART B-GENERAL & SYSTEMATIC PHARMACOLOGY, 1975, 1 (03) :407-421

[2]

BERRAUER K, 1987, Patent No. 8727854

[3]

BIRKMAYER W, 1961, Wien Klin Wochenschr, V73, P787

[4]

CALNE DB, 1973, CLIN PHARMACOL THER, V14, P386

[5] CLINICAL-SIGNIFICANCE OF THE RELATIONSHIP BETWEEN O-METHYLDOPA LEVELS AND LEVODOPA INTAKE [J].

CEDARBAUM, JM ;

KUTT, H ;

MCDOWELL, FH .

NEUROLOGY, 1988, 38 (04) :533-536

[6] CLINICAL PHARMACOKINETICS OF ANTI-PARKINSONIAN DRUGS [J].

CEDARBAUM, JM .

CLINICAL PHARMACOKINETICS, 1987, 13 (03) :141-178

[7] POTENTIATION OF L-DOPA EFFECT IN MAN BY USE OF CATECHOL-O-METHYLTRANSFERASE INHIBITORS [J].

ERICSSON, AD .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1971, 14 (02) :193-&

[8] ON-OFF PHENOMENON WITH LEVODOPA THERAPY IN PARKINSONISM - CLINICAL AND PHARMACOLOGIC CORRELATIONS AND EFFECT OF INTRAMUSCULAR PYRIDOXINE [J].

FAHN, S .

NEUROLOGY, 1974, 24 (05) :431-441

[9]

FEUERSTEIN C, 1977, ACTA NEUROL SCAND, V56, P79

[10]

GERVAS JJ, 1983, NEUROLOGY, V33, P278, DOI 10.1212/WNL.33.3.278

← 1 2 3 →